News

The OPTN announces an update to median MELD at transplant (MMaT) values, which affect many liver transplant candidates with exception scores.

OPTN is seeking feedback on a proposed bylaw addition that would establish a code of conduct for OPTN volunteers.

Access “Medical Device Reporting (MDR) Reporting Requirements,” a presentation by the Food and Drug Administration (FDA) to OPTN committee members.

Access “Regulation of Allograft Heart Valves,” a presentation by the FDA to the OPTN Operations and Safety Committee on July 27, 2023.

Access a HRSA and CMS webinar soliciting feedback on the Organ Transplantation Affinity Group (OTAG)'s framework, purpose, goals, and action plan.

Read recommendations from the OPTN Membership and Professional Standards Committee (MPSC) on reporting patient safety events and other topics.

Learn about the pre-transplant mortality rate ratio, a new risk-adjusted pre-transplant performance monitoring metric, to take effect July 25, 2024.

Learn about the OPTN Executive Committee's formation of two ad hoc work groups: the Code of Conduct Work Group and the OPTN Prioritization Work Group.

Read an important message from the OPTN Board President, Dianne LaPointe Rudow, ANP-BC, DNP, FAAN, on OPTN Board independence.

Read a data monitoring report showing that lung transplants for blood type O increased after implementation of a modified blood type rating scale.